Artelo Biosciences Inc.

1.16+0.0300+2.65%Vol 1.17M1Y Perf 0.94%
Apr 16th, 2021 16:00 DELAYED
BID1.16 ASK1.18
Open1.10 Previous Close1.13
Pre-Market- After-Market-
 - -  - -%
Target Price
6.00 
Analyst Rating
Hold 3.00
Potential %
417.24 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap18.23M 
Earnings Rating
Price Range Ratio 52W %
22.03 
Earnings Date
13th Apr 2021

Today's Price Range

1.051.17

52W Range

0.45103.67

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-23.68%
1 Month
-43.41%
3 Months
19.59%
6 Months
85.01%
1 Year
0.94%
3 Years
-84.66%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ARTL1.160.03002.65
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Earnings HistoryEstimateReportedSurprise %
Q02 2021--0.11-
Q01 2021--0.14-
Q04 2020--0.20-
Q03 2020--0.27-
Q02 2020--0.40-
Q01 2020--0.38-
Q04 2019--0.42-
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.17M
Shares Outstanding15.71M
Trades Count3.86K
Dollar Volume4.14M
Avg. Volume8.22M
Avg. Weekly Volume1.21M
Avg. Monthly Volume1.17M
Avg. Quarterly Volume8.75M

Artelo Biosciences Inc. (NASDAQ: ARTL) stock closed at 1.16 per share at the end of the most recent trading day (a 2.65% change compared to the prior day closing price) with a volume of 1.17M shares and market capitalization of 18.23M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 2 people. Artelo Biosciences Inc. CEO is Gregory D. Gorgas.

The one-year performance of Artelo Biosciences Inc. stock is 0.94%, while year-to-date (YTD) performance is 58.9%. ARTL stock has a five-year performance of %. Its 52-week range is between 0.451 and 3.67, which gives ARTL stock a 52-week price range ratio of 22.03%

Artelo Biosciences Inc. currently has a PE ratio of -1.60, a price-to-book (PB) ratio of 2.74, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -259.51%, a ROC of -9 372.53% and a ROE of -9 372.53%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Artelo Biosciences Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Artelo Biosciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Artelo Biosciences Inc. is Hold (3), with a target price of $6, which is +417.24% compared to the current price. The earnings rating for Artelo Biosciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Artelo Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Artelo Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 37.39, ATR14 : 0.29, CCI20 : -189.09, Chaikin Money Flow : -0.32, MACD : -0.10, Money Flow Index : 16.60, ROC : -25.64, RSI : 45.04, STOCH (14,3) : 15.49, STOCH RSI : 0.09, UO : 39.39, Williams %R : -84.51), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Artelo Biosciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Strong Buy
1.00

Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

CEO: Gregory D. Gorgas

Telephone: +1 760 943-1689

Address: 888 Prospect Street, San Diego 92037, CA, US

Number of employees: 2

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

56%44%

News

Stocktwits